Research and Development

It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …

In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …

It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …

The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …

Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …

AstraZeneca and MedImmune, the company’s biologics research and development division, have revealed the decision by the FDA to approve Fasenra …

Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the …

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …

Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …

Swedish biopharma firm Hansa Medical broke tragic and unexpected news in November when it announced the death of its CEO …